311 related articles for article (PubMed ID: 30200422)
1. Metabolically Healthy versus Unhealthy Morbidly Obese: Chronic Inflammation, Nitro-Oxidative Stress, and Insulin Resistance.
Cӑtoi AF; Pârvu AE; Andreicuț AD; Mironiuc A; Crӑciun A; Cӑtoi C; Pop ID
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30200422
[TBL] [Abstract][Full Text] [Related]
2. Should we wait for metabolic complications before operating on obese patients? Gastric bypass outcomes in metabolically healthy obese individuals.
Pelascini E; Disse E; Pasquer A; Poncet G; Gouillat C; Robert M
Surg Obes Relat Dis; 2016 Jan; 12(1):49-56. PubMed ID: 26164112
[TBL] [Abstract][Full Text] [Related]
3. Can bariatric surgery improve cardiovascular risk factors in the metabolically healthy but morbidly obese patient?
Goday A; Benaiges D; Parri A; Ramón JM; Flores-Le Roux JA; Pedro Botet J;
Surg Obes Relat Dis; 2014; 10(5):871-6. PubMed ID: 25282193
[TBL] [Abstract][Full Text] [Related]
4. Chemerin, Inflammatory, and Nitrooxidative Stress Marker Changes Six Months after Sleeve Gastrectomy.
Cӑtoi AF; Pârvu AE; Mironiuc A; Chiorescu Ş; Crӑciun A; Pop ID; Cӑtoi C
Oxid Med Cell Longev; 2018; 2018():1583212. PubMed ID: 29849863
[TBL] [Abstract][Full Text] [Related]
5. Leptin to adiponectin ratio - A surrogate biomarker for early detection of metabolic disturbances in obesity.
Larsen MA; Isaksen VT; Moen OS; Wilsgaard L; Remijn M; Paulssen EJ; Florholmen J; Goll R
Nutr Metab Cardiovasc Dis; 2018 Nov; 28(11):1114-1121. PubMed ID: 30145019
[TBL] [Abstract][Full Text] [Related]
6. Metabolically Healthy Obesity Is Characterized by a Proinflammatory Phenotype of Circulating Monocyte Subsets.
Christou KA; Christou GA; Karamoutsios A; Vartholomatos G; Gartzonika K; Tsatsoulis A; Tigas S
Metab Syndr Relat Disord; 2019 Jun; 17(5):259-265. PubMed ID: 30864887
[No Abstract] [Full Text] [Related]
7. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.
Sell H; Divoux A; Poitou C; Basdevant A; Bouillot JL; Bedossa P; Tordjman J; Eckel J; Clément K
J Clin Endocrinol Metab; 2010 Jun; 95(6):2892-6. PubMed ID: 20375212
[TBL] [Abstract][Full Text] [Related]
8. Chemerin is associated with inflammatory markers and metabolic syndrome phenotypes in hypertension patients.
Gu P; Jiang W; Lu B; Shi Z
Clin Exp Hypertens; 2014; 36(5):326-32. PubMed ID: 24047472
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine is the confounding factor of metabolic syndrome-confirmed by siMS score.
Srećković B; Soldatovic I; Colak E; Mrdovic I; Sumarac-Dumanovic M; Janeski H; Janeski N; Gacic J; Dimitrijevic-Sreckovic V
Drug Metab Pers Ther; 2018 Jun; 33(2):99-103. PubMed ID: 29624500
[TBL] [Abstract][Full Text] [Related]
10. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
[TBL] [Abstract][Full Text] [Related]
11. Link between chemerin, central obesity, and parameters of the Metabolic Syndrome: findings from a longitudinal study in obese children participating in a lifestyle intervention.
Niklowitz P; Rothermel J; Lass N; Barth A; Reinehr T
Int J Obes (Lond); 2018 Oct; 42(10):1743-1752. PubMed ID: 30030480
[TBL] [Abstract][Full Text] [Related]
12. Metabolic effects of bariatric surgery in insulin-sensitive morbidly obese subjects.
Jiménez A; Perea V; Corcelles R; Moizé V; Lacy A; Vidal J
Obes Surg; 2013 Apr; 23(4):494-500. PubMed ID: 23184406
[TBL] [Abstract][Full Text] [Related]
13. Chemerin and apelin are positively correlated with inflammation in obese type 2 diabetic patients.
Yu S; Zhang Y; Li MZ; Xu H; Wang Q; Song J; Lin P; Zhang L; Liu Q; Huang QX; Wang K; Hou WK
Chin Med J (Engl); 2012 Oct; 125(19):3440-4. PubMed ID: 23044303
[TBL] [Abstract][Full Text] [Related]
14. Individuals with Metabolically Healthy Overweight/Obesity Have Higher Fat Utilization than Metabolically Unhealthy Individuals.
Pujia A; Gazzaruso C; Ferro Y; Mazza E; Maurotti S; Russo C; Lazzaro V; Romeo S; Montalcini T
Nutrients; 2016 Jan; 8(1):. PubMed ID: 26742056
[TBL] [Abstract][Full Text] [Related]
15. Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkers.
Landucci Bonifácio K; Sabbatini Barbosa D; Gastaldello Moreira E; de Farias CC; Higachi L; Camargo AEI; Favaro Soares J; Odebrecht Vargas H; Nunes SOV; Berk M; Dodd S; Maes M
J Affect Disord; 2017 Nov; 222():185-194. PubMed ID: 28710952
[TBL] [Abstract][Full Text] [Related]
16. Oxidative and endoplasmic reticulum stress is impaired in leukocytes from metabolically unhealthy vs healthy obese individuals.
Bañuls C; Rovira-Llopis S; Lopez-Domenech S; Diaz-Morales N; Blas-Garcia A; Veses S; Morillas C; Victor VM; Rocha M; Hernandez-Mijares A
Int J Obes (Lond); 2017 Oct; 41(10):1556-1563. PubMed ID: 28630460
[TBL] [Abstract][Full Text] [Related]
17. Metabolic alterations in morbid obesity. Influence on the haemorheological profile.
Vayá A; Hernández-Mijares A; Suescun M; Solá E; Cámara R; Romagnoli M; Bautista D; Laiz B
Clin Hemorheol Microcirc; 2011; 48(4):247-55. PubMed ID: 22012830
[TBL] [Abstract][Full Text] [Related]
18. Bariatric surgery improves metabolic and nonalcoholic fatty liver disease markers in metabolically healthy patients with morbid obesity at 5 years.
Goday A; Julià H; de Vargas-Machuca A; Pedro-Botet J; Benavente S; Ramon JM; Pera M; Casajoana A; Villatoro M; Fontané L; Bisbe M; Climent E; Castañer O; Flores Le Roux JA; Benaiges D
Surg Obes Relat Dis; 2021 Dec; 17(12):2047-2053. PubMed ID: 34509375
[TBL] [Abstract][Full Text] [Related]
19. Correlation of resistin with inflammatory and cardiometabolic markers in obese adolescents with and without metabolic syndrome.
Makni E; Moalla W; Benezzeddine-Boussaidi L; Lac G; Tabka Z; Elloumi M
Obes Facts; 2013; 6(4):393-404. PubMed ID: 23970148
[TBL] [Abstract][Full Text] [Related]
20. Morbidly "Healthy" Obese Are Not Metabolically Healthy but Less Metabolically Imbalanced Than Those with Type 2 Diabetes or Dyslipidemia.
Ferrer R; Pardina E; Rossell J; Oller L; Viñas A; Baena-Fustegueras JA; Lecube A; Vargas V; Balibrea JM; Caubet E; González O; Vilallonga R; Fort JM; Peinado-Onsurbe J
Obes Surg; 2015 Aug; 25(8):1380-91. PubMed ID: 25515498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
